World Health Organization Chief Tedros Adhanom Ghebreyesus Never Stops Worrying
I am afraid for Dr. Tedros’ safety. The World Health Organization Director-General and I are walking from the WHO’s midtown-Manhattan offices to the nearby U.N. campus, where Tedros is participating in the U.N. General Assembly. As we cross avenues amid a chorus of honking horns, Tedros is so intent on answering my questions, rarely breaking eye contact, that he appears not to notice traffic lights changing and cyclists whizzing past at alarming proximity. His staff and I breathe a collective sigh of relief when he arrives at the U.N. unscathed. It should come as no surprise that the man at the helm of the worl...
Source: TIME: Health - November 21, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized climate change health World Health Organization Source Type: news

Congo-Kinshasa: New Ebola Vaccine Enters Real-World Test Phase
[Deutsche Welle] Authorities in the Democratic Republic of Congo have started using a second vaccine to fight Ebola. The country is struggling to contain what is now the world's second-worst outbreak of the deadly virus on record. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 15, 2019 Category: African Health Source Type: news

First Ebola Vaccine Approved by European Commission
THURSDAY, Nov. 14, 2019 -- The world's first Ebola vaccine has been approved by the European Commission, and it was quickly prequalified by the World Health Organization. The Ervebo vaccine is made by Merck and is being used in a " compassionate use " ... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 14, 2019 Category: Pharmaceuticals Source Type: news

Rollout of Johnson & Johnson Ebola vaccine begins in Congo
Health authorities in eastern Congo have introduced a new Ebola vaccine produced by Johnson& Johnson, aid group MSF said on Thursday, to help combat the world's second-worst outbreak of the virus on record. (Source: Reuters: Health)
Source: Reuters: Health - November 14, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Ebola vaccine approved as second jab trialled
A second Ebola vaccine is to be offered to thousands of people in the Democratic Republic of Congo. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - November 13, 2019 Category: Consumer Health News Source Type: news

Congo-Kinshasa: EU Approval of First Ebola Vaccine is Game Changer
[VOA] This week the European Commission gave approval to a Ebola vaccine -- an act that the World Health Organization calls landmark moment for global health and a likely game-changer in the battle against this deadly disease. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 13, 2019 Category: African Health Source Type: news

Merck Wins European Approval for First-Ever Ebola Vaccine Merck Wins European Approval for First-Ever Ebola Vaccine
U.S. drugmaker Merck& Co Inc on Monday received approval from the European Commission to market its Ebola vaccine, less than a month after a European medicines panel backed the first-ever vaccine against the deadly virus.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 13, 2019 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Tuesday's Daily Brief: ‘Forgotten’ pneumonia epidemic, experts urge vigilance over Australia wildfires, Ebola vaccine breakthrough 
A recap of Tuesday’s top stories: Pneumonia number one killer of children; Australia’s wildfires rage on; Ebola vaccine gets green light; new child labour and trafficking study; Malnutrition soars in Latin America and Caribbean; Intellectual Property chief encourages innovation. (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - November 12, 2019 Category: International Medicine & Public Health Source Type: news

Merck wins European approval to market first-ever Ebola vaccine
U.S. drugmaker Merck & Co Inc on Monday received approval from the European Commission to market its Ebola vaccine. (Source: CBC | Health)
Source: CBC | Health - November 12, 2019 Category: Consumer Health News Tags: News/Health Source Type: news

The Ebola Vaccine Is Now Officially Here With Approval In Europe
In big global health news, the European Commission has granted Merck Sharp and Dohme B.V. marketing authorization in Europe for Ervebo. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 12, 2019 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

Ebola Vaccine Approved for Use in Europe
Merck's Ervebo gets its first regulatory greenlight. A decision from the US Food and Drug Administration is expected in the next few months. (Source: The Scientist)
Source: The Scientist - November 11, 2019 Category: Science Tags: News & Opinion Source Type: news

Merck wins European approval for first-ever Ebola vaccine
U.S. drugmaker Merck& Co Inc on Monday received approval from the European Commission to market (http://bit.ly/2NZ0QMB) its Ebola vaccine, less than a month after a European medicines panel backed the first-ever vaccine against the deadly virus. (Source: Reuters: Health)
Source: Reuters: Health - November 11, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Study vaccine protects monkeys against four types of hemorrhagic fever viruses
The vaccine provided protection from Ebola virus, Sudan virus, Marburg virus and Lassa virus. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - November 8, 2019 Category: American Health Source Type: news

Johnson & Johnson Announces Submission of European Marketing Authorisation Applications for Janssen ’s Investigational Ebola Vaccine Regimen
Data from multiple preclinical, Phase 1, 2 and 3 studies support applications, which have been granted Accelerated Assessment by European Medicines Agency (Source: Johnson and Johnson)
Source: Johnson and Johnson - November 7, 2019 Category: Pharmaceuticals Source Type: news

Johnson & Johnson files for European approval of Ebola vaccine
Johnson& Johnson said on Thursday it had filed for an approval from European regulators for its two-dose experimental vaccine to protect against Ebola, less than a month after the agency recommended approval of Merck& Co Inc's vaccine. (Source: Reuters: Health)
Source: Reuters: Health - November 7, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Johnson & Johnson Announces Donation of up to 500,000 Regimens of Janssen ’s Investigational Ebola Vaccine to Support Outbreak Response in Democratic Republic of the Congo (DRC)
The government of the DRC supports use of Janssen ’s vaccine regimen as part of expanded public health response to country’s Ebola outbreak – the second-worst on record (Source: Johnson and Johnson)
Source: Johnson and Johnson - October 31, 2019 Category: Pharmaceuticals Source Type: news

First vaccine to protect against Ebola
EMA's human medicines committee (CHMP) has recommended granting a conditional marketing authorisation in the European Union for Ervebo (rVSVΔG-ZEBOV-GP), the first vaccine for active immunisation of individuals aged 18 years and older at risk of infection with the Ebola virus. (Source: World Pharma News)
Source: World Pharma News - October 28, 2019 Category: Pharmaceuticals Tags: Featured EMA Regulatory Affairs Source Type: news

Community Health Workers Are Vital; Governments Should Be Paying Them
Illness is universal, health care is not. Over half of the world’s 7.3 billion people, including 1 billion in rural communities, lack access to health care. Approximately 13 million children still go without a single dose of any vaccine. Nearly 9 million newborns, children and mothers still die each year from preventable or treatable conditions. Compounding this crisis is a massive health-worker shortage, forecast to grow to 18 million by 2030. Training more doctors is necessary, but because doctors are concentrated in cities, they alone are insufficient to close this gap. What if the residents of rural communities&n...
Source: TIME: Health - October 24, 2019 Category: Consumer Health News Authors: Dr. Raj Panjabi Tags: Uncategorized Healthcare Source Type: news

EU Panel Gives Thumbs-Up on First Ebola Vaccine EU Panel Gives Thumbs-Up on First Ebola Vaccine
The V920 Ebola Zaire vaccine (Ervebo, Merck) protects against Ebola virus disease caused by Zaire Ebola virus in at-risk adults aged 18 years or older.International Approvals (Source: Medscape Med Students Headlines)
Source: Medscape Med Students Headlines - October 18, 2019 Category: Universities & Medical Training Tags: Infectious Diseases News Alert Source Type: news

W.H.O. Continues Emergency Status for Ebola Outbreak in Congo
New cases are down to 15 a week from a high of 128 in April, but outbreaks are still popping up in remote and dangerous mining areas. (Source: NYT Health)
Source: NYT Health - October 18, 2019 Category: Consumer Health News Authors: Donald G. McNeil Jr. Tags: Ebola Virus Epidemics Disasters and Emergencies Vaccination and Immunization World Health Organization Tedros Adhanom Ghebreyesus Congo, Democratic Republic of (Congo-Kinshasa) Uganda Source Type: news

European drug regulators approve world's first Ebola vaccine after its 'success' in Congo
The so-called Merck vaccine was approved his afternoon and is likely to get a full marketing licence from the European Commission within a few weeks. (Source: the Mail online | Health)
Source: the Mail online | Health - October 18, 2019 Category: Consumer Health News Source Type: news

WHO hails 'triumph' as Merck's Ebola vaccine gets European green light
The world's first Ebola vaccine was recommended for approval by European drugs regulators on Friday in a move hailed by the World Health Organization (WHO) as a "triumph for public health" that would save many lives. (Source: Reuters: Health)
Source: Reuters: Health - October 18, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

World's 1st Ebola vaccine gets green light from EU regulator
World Health Organization calls European recommendation for an Ebola vaccine originally developed in Canada a major milestone. (Source: CBC | Health)
Source: CBC | Health - October 18, 2019 Category: Consumer Health News Tags: News/Health Source Type: news

Candidate Ebola Vaccine Still Effective when Highly Diluted, Macaque Study Finds
Scientists Hope Findings Mean Vaccine Supplies Could Stretch Farther. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - October 18, 2019 Category: American Health Source Type: news

Nigeria: Congo to Start Using Johnson & Johnson Ebola Vaccine in November
[Vanguard] Health authorities in the Democratic Republic of Congo will introduce a Johnson& Johnson Ebola vaccine in November in the country's eastern provinces, to counter the current outbreak, they said. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 14, 2019 Category: African Health Source Type: news

Congo-Kinshasa: New Ebola Vaccine Brings Hope
[Deutsche Welle] Many in the Democratic Republic of Congo have been waiting for this moment: A new vaccine to battle the Ebola outbreak is about to be released. The vaccine could reach broader parts of the population than before. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 14, 2019 Category: African Health Source Type: news

Congo to start using Johnson & Johnson Ebola vaccine in November
Health authorities in Democratic Republic of Congo will introduce a Johnson& Johnson Ebola vaccine in November in the country's eastern provinces, to counter the current outbreak, they said. (Source: Reuters: Health)
Source: Reuters: Health - October 13, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Rwanda: Rwanda Planning Massive Vaccination Campaign Against Ebola
[New Times] Rwanda is planning a big vaccination campaign against the Ebola Virus Disease (EBV) for adults, adolescents, and children aged two years living within the vicinity of a possible Ebola outbreak. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 13, 2019 Category: African Health Source Type: news

More Than 4,000 People Died From Measles in World ’s Largest Outbreak in Congo
(DAKAR, Senegal) — More than 4,000 people have died in Congo this year in the world’s largest measles outbreak, the United Nations children’s agency said Wednesday. The Central African nation is also battling an Ebola outbreak that has killed about half that number since August 2018. Since January, more than 200,000 cases of measles have been reported across Congo, UNICEF said. More than 140,000 involve children under 5, who also make up nearly 90 percent of deaths. “We’re facing this alarming situation because millions of Congolese children miss out on routine immunization and lack access to ...
Source: TIME: Health - October 9, 2019 Category: Consumer Health News Authors: CARLEY PETESCH / AP Tags: Uncategorized Disease onetime the Democratic Republic of Congo Source Type: news

Congo-Kinshasa: Vaccinating Against Ebola - the Challenges of Containing the Outbreak
[MSF] Esther only winces slightly when a doctor on Doctors Without Borders/M édecins Sans Frontières' (MSF) vaccination team injects the Ebola vaccine called rVSV-ZEBOV into her left upper arm in Kimbangu, a community in the southwest of Beni--one of the recurring hotspots of the current Ebola epidemic in North Kivu province of the Democratic Republic of Congo (DRC). Justi n*, her two-and-a-half year-old son, bursts into tears when he sees a new syringe being filled, and only calms down a few minutes (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 3, 2019 Category: African Health Source Type: news

Health Experts Fight Ebola in Congo, and Each Other
As the epidemic rages in a violent, embattled region, two important players — the World Health Organization and Doctors Without Borders — clash over how to end it. (Source: NYT Health)
Source: NYT Health - September 24, 2019 Category: Consumer Health News Authors: Denise Grady Tags: your-feed-science Epidemics Ebola Virus Vaccination and Immunization Infections Doctors Without Borders World Health Organization Johnson & Merck Company Inc Congo, Democratic Republic of (Congo-Kinshasa) Tanzania Source Type: news

Aid group says vaccine 'rationing' in Congo is hampering Ebola fight
The World Health Organization is "rationing" Ebola vaccines in Democratic Republic of Congo, with access controls meaning too few people at risk are being protected in an outbreak of the deadly disease, the aid group MSF said on Monday. (Source: Reuters: Health)
Source: Reuters: Health - September 23, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Doctors Without Borders Calls For More Transparency In Distribution Of Ebola Vaccine
The international humanitarian group says the World Health Organization is restricting access to the vaccine in the Democratic Republic of Congo, where the current outbreak has killed more than 2,100.(Image credit: Jerome Delay/AP) (Source: NPR Health and Science)
Source: NPR Health and Science - September 23, 2019 Category: Consumer Health News Authors: Paolo Zialcita Source Type: news

2nd Ebola vaccine to be used in Congo, as UN efforts slammed
The World Health Organization on Monday announced Congo will start using a second experimental Ebola vaccine, as efforts to stop the deadly outbreak are stalled and Doctors Without Borders criticizes vaccination efforts to date. (Source: CBC | Health)
Source: CBC | Health - September 23, 2019 Category: Consumer Health News Tags: News/Health Source Type: news

2nd Ebola vaccine to be used in Congo, as UN efforts slammed
The move comes as efforts to stop the deadly outbreak are stalled. (Source: ABC News: Health)
Source: ABC News: Health - September 23, 2019 Category: Consumer Health News Tags: Health Source Type: news

Congo-Kinshasa: WHO Is Limiting Doses of Ebola Vaccine - Doctors Without Borders
[MSF] Paris/Goma -More than a year into the ongoing Ebola outbreak in northeastern Democratic Republic of Congo (DRC), the disease has killed over 2,000 people. The mortality rate in this outbreak is around 67 per cent(1), which is comparable with the mortality rate in the 2014-2016 West Africa outbreak, when neither therapeutic treatments, nor a vaccine, were available. While a highly effective vaccine is now able to offer some protection, the number of people vaccinated is not enough. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 23, 2019 Category: African Health Source Type: news

Congo to deploy second Ebola vaccine
Health authorities in Democratic Republic of Congo said on Saturday that they plan to introduce a second Ebola vaccine, manufactured by Johnson& Johnson, to counter the second-worst outbreak of the virus in history. (Source: Reuters: Health)
Source: Reuters: Health - September 21, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

FDA grants priority review to Merck Ebola vaccine
The organization granted Breakthrough Therapy Designation to V920 in July 2016 and it now has a target action date of March 14, 2020 (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - September 17, 2019 Category: Pharmaceuticals Source Type: news

British doctor who helped fight Ebola praises an experimental vaccine
Dr Catherine Houlihan, from Aberdeen, returned home to the UK from the African nation in June after spending a month at the heart of the epidemic in the North Kivu province. (Source: the Mail online | Health)
Source: the Mail online | Health - September 10, 2019 Category: Consumer Health News Source Type: news

Developing a Toolkit to Assess Efficacy of Ebola Vaccines and Therapeutics
MCMi regulatory science project to research issues that are key to understanding and predicting if —and how—vaccines and therapeutics to prevent and treat Ebola will show efficacy (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - August 28, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Debate over vaccination strategies dogs Ebola efforts in Congo
New vaccine from J&J could supplement current shot from Merck (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - August 27, 2019 Category: Pharmaceuticals Source Type: news

How an Ebola research project could help combat vaccine disinformation in Canada
A Canadian research project in Congo centred on how to build trust in communities could help efforts to fight the spread of Ebola, measles and many other diseases around the world. (Source: CBC | Health)
Source: CBC | Health - August 26, 2019 Category: Consumer Health News Tags: News/Health Source Type: news

Congo has given over 200,000 people Merck Ebola vaccine: government
Congolese authorities and health workers vaccinated more than 200,000 people against Ebola in August, the government said on Sunday, using a Merck vaccine they hope will help rein in the world's second worst epidemic. (Source: Reuters: Health)
Source: Reuters: Health - August 25, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

HHS to Provide $23 Mln to Merck for Ebola Vaccine Production HHS to Provide $23 Mln to Merck for Ebola Vaccine Production
The U.S. Department of Health and Human Services (HHS) said on Wednesday it will fund the manufacturing of Merck& Co Inc's investigational Ebola vaccine called V920, in response to the outbreak of the deadly virus in the Democratic Republic of the Congo (DRC).Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 23, 2019 Category: Consumer Health News Tags: Medscape Today News Source Type: news

HHS to provide $23 million to Merck for Ebola vaccine production
The U.S. Department of Health and Human Services (HHS) said on Wednesday it will fund the manufacturing of Merck& Co Inc's investigational Ebola vaccine called V920, in response to the outbreak of the deadly virus in the Democratic Republic of the Congo (DRC). (Source: Reuters: Health)
Source: Reuters: Health - August 21, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Rwanda: Rwanda Fast Tracking Purchase of Ebola Vaccine
[New Times] Rwanda is in talks to acquire at least 100,000 doses of an Ebola vaccine for a mass vaccination campaign that targets traders around the country's border with DR Congo, according to reports. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 21, 2019 Category: African Health Source Type: news

A ‘Cure’ for Ebola but Will it Stop the Outbreak if People Won’t Get Treatment?
Health workers inside a "CUBE" talk to an Ebola patient, while a nurse consults a chart outside. ALIMA Ebola Treatment Centre, Beni, Democratic Republic of the Congo. Two drugs have been found to successfully treat the Ebola virus. Aid agencies have welcomed the news saying it allows communities to access early treatment. Courtesy: World Health Organisation (WHO)By Issa Sikiti da SilvaCOTONOU, Benin, Aug 20 2019 (IPS) While people in the Democratic Republic of Congo (DRC) are slowly being made aware that scientists have discovered two drugs that are effective in treating Ebola, letting go of the fear and anxiety ...
Source: IPS Inter Press Service - Health - August 20, 2019 Category: International Medicine & Public Health Authors: Issa Sikiti da Silva Tags: Africa Development & Aid Editors' Choice Featured Health Human Rights Humanitarian Emergencies Population Poverty & SDGs Regional Categories TerraViva United Nations Democratic Republic of Congo (DRC) ebola Source Type: news

Congo-Kinshasa: Ebola Crisis-The Vaccines Debate
[Ghanaian Times] As I write this piece, the Democratic Republic of Congo (DRC) is reeling from an Ebola crisis with the World Health Organization (WHO) having declared it a global health emergency. It is reported to have killed about 1,800 people so far. The crisis has been worsened by internal conflicts and mobility of people fleeing from the conflicts. I will continue with information gleaned from the BBC and Bloomberg on the Ebola crisis and deployment of vaccines. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 16, 2019 Category: African Health Source Type: news

Burundi Starts Ebola Vaccines for Health Workers -WHO Burundi Starts Ebola Vaccines for Health Workers -WHO
Burundi has started vaccinating its health workers against Ebola, beginning with those near the border with the Democratic Republic of Congo, the World Health Organization (WHO) said on Wednesday.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 16, 2019 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news

Burundi: Govt Launches Ebola Vaccination Campaign for Health and Front-Line Workers
[WHO] On 13th August, the Ministry of Public Health and AIDS Control kicked off the vaccination campaign for front-line staff against the Ebola virus disease. The campaign started at the Gatumba entry point at the Border with the Democratic Republic of Congo. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 15, 2019 Category: African Health Source Type: news